Clinical trials in PKD currently ongoing at KUMC
If you would like more information regarding the trial or how to participate, please contact the study coordinator or complete the Nephrology Clinical Research Interest Form and we will contact you.
|Trial Name||Sponsor||Summary||Details||Study Coordinator|
|EPOC PKD||NIH||This observational study will collect blood and urine and clinical information from individuals with early-stages of polycystic kidney disease (PKD), The long-term goal is to develop new knowledge of biomarkers that indicate changes in the disease progression. An understanding of biomarkers will benefit PKD patients as new therapies are being developed and tested.||
|FALCON||REATA||FALCON is a Phase 3 clinical study evaluating the effectiveness and safety of bardoxolone methyl (an oral investigational drug) in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD).||
|PKD Repository||KUMC Jared Grantham Kidney Institute||The University of Kansas Medical Center is establishing a biorepository of blood and urine samples from adults with Polycystic Kidney Disease (PKD) in order to provide specimens to investigators for the discovery of biomarkers.
Biomarkers may help monitor PKD progression and determine the effectiveness of new treatments
General Nephrology Coordinators
Cathy Creed, RN
Debbie Griffin, RN, CDE
Nephrology Transplant Coordinators